HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuetao Cao Selected Research

tautomycetin

3/2014Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuetao Cao Research Topics

Disease

113Neoplasms (Cancer)
01/2022 - 01/2002
36Inflammation (Inflammations)
10/2022 - 01/2003
26Infections
01/2022 - 03/2004
25Virus Diseases (Viral Diseases)
01/2022 - 06/2006
16Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2002
15Autoimmune Diseases (Autoimmune Disease)
10/2022 - 04/2005
15Breast Neoplasms (Breast Cancer)
01/2021 - 01/2003
10Neoplasm Metastasis (Metastasis)
01/2019 - 06/2002
8Bacterial Infections (Bacterial Infection)
01/2022 - 11/2010
8Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021 - 04/2005
7Colitis
11/2020 - 08/2014
7Carcinogenesis
10/2020 - 05/2008
6Colonic Neoplasms (Colon Cancer)
05/2020 - 01/2008
6Septic Shock (Toxic Shock Syndrome)
01/2019 - 01/2009
6Vesicular Stomatitis
02/2014 - 03/2008
5Sepsis (Septicemia)
01/2022 - 04/2012
5Lung Neoplasms (Lung Cancer)
05/2020 - 04/2007
4Bites and Stings (Sting)
01/2019 - 02/2015
4Hypersensitivity (Allergy)
12/2014 - 05/2010
4Leukemia
11/2009 - 02/2003
4Carcinoma (Carcinomatosis)
05/2009 - 09/2002
4Experimental Melanoma
07/2005 - 09/2002
4Necrosis
04/2004 - 02/2002
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022 - 04/2011
3Communicable Diseases (Infectious Diseases)
11/2021 - 03/2004
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2020 - 01/2010
3Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 03/2014
3RNA Virus Infections
02/2016 - 11/2010
3Ovarian Neoplasms (Ovarian Cancer)
04/2010 - 09/2006
3Adenocarcinoma
06/2004 - 01/2003
2Liver Neoplasms (Liver Cancer)
03/2022 - 10/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 07/2010

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
03/2022 - 09/2002
26CytokinesIBA
03/2022 - 09/2002
19Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 07/2002
14Interleukin-6 (Interleukin 6)IBA
03/2022 - 05/2008
14AntigensIBA
01/2022 - 05/2002
14Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 04/2005
12LigandsIBA
01/2021 - 07/2002
12Interferon Type IIBA
01/2021 - 05/2011
12Antiviral Agents (Antivirals)IBA
01/2020 - 08/2009
10VaccinesIBA
11/2021 - 11/2002
10Cancer VaccinesIBA
09/2015 - 11/2002
9Pattern Recognition ReceptorsIBA
11/2021 - 04/2013
9MicroRNAs (MicroRNA)IBA
10/2020 - 11/2010
8ChemokinesIBA
10/2021 - 04/2007
8Interleukin-10 (Interleukin 10)IBA
11/2020 - 05/2009
8Messenger RNA (mRNA)IBA
01/2020 - 10/2002
7Long Noncoding RNAIBA
11/2021 - 11/2017
7Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021 - 01/2008
7Phosphatidylethanolamine Binding ProteinIBA
01/2021 - 10/2005
7LipopolysaccharidesIBA
01/2019 - 07/2002
7NF-kappa B (NF-kB)IBA
01/2016 - 04/2007
6InterferonsIBA
11/2021 - 07/2011
6DNA (Deoxyribonucleic Acid)IBA
11/2021 - 01/2002
6Phosphotransferases (Kinase)IBA
01/2021 - 11/2009
6IntegrinsIBA
11/2020 - 11/2009
5RNA (Ribonucleic Acid)IBA
01/2022 - 10/2017
5MethyltransferasesIBA
01/2020 - 09/2013
5Pharmaceutical PreparationsIBA
03/2014 - 04/2008
4Nucleic AcidsIBA
11/2021 - 06/2010
4Monomeric GTP-Binding ProteinsIBA
03/2021 - 06/2004
4ChromatinIBA
01/2021 - 09/2015
4Dinoprostone (PGE2)FDA Link
05/2020 - 03/2009
4Sirolimus (Rapamycin)FDA Link
05/2020 - 05/2008
4SuperantigensIBA
02/2020 - 09/2002
4Biological ProductsIBA
10/2019 - 06/2006
4Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2013
4Peptides (Polypeptides)IBA
01/2018 - 05/2002
4Small Interfering RNA (siRNA)IBA
10/2017 - 10/2004
4Transforming Growth Factor beta (TGF-beta)IBA
05/2014 - 08/2002
4HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
03/2014 - 11/2002
4Interleukin-18 (Interleukin 18)IBA
01/2013 - 09/2003
4Prostaglandins EIBA
05/2009 - 05/2008
4Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2009 - 03/2004
3N-methyladenosineIBA
01/2022 - 10/2017
3AcidsIBA
01/2022 - 02/2007
36-methyladenineIBA
01/2022 - 01/2019
3Apoptosis Regulatory ProteinsIBA
10/2021 - 12/2008
3RNA Precursors (Precursor, mRNA)IBA
01/2021 - 03/2004
3Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2020 - 01/2009
3EnzymesIBA
01/2020 - 10/2002
3Membrane Proteins (Integral Membrane Proteins)IBA
01/2019 - 01/2007
3KynurenineIBA
12/2018 - 10/2017
3Dextran SulfateIBA
11/2018 - 09/2015
3Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2017 - 11/2010
3Interleukin-12 (IL 12)IBA
01/2017 - 10/2003
3Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2014
3Interleukin-17 (Interleukin 17)IBA
06/2015 - 05/2010
3Pathogen-Associated Molecular Pattern MoleculesIBA
12/2014 - 04/2005
3CollagenIBA
11/2012 - 08/2002
3Interleukin-2 (IL2)IBA
06/2007 - 01/2003
3Neoplasm Antigens (Tumor Antigens)IBA
07/2005 - 05/2002
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 10/2021
2Biocompatible Materials (Biomaterials)IBA
02/2021 - 12/2020
2Growth InhibitorsIBA
01/2021 - 02/2005

Therapy/Procedure

23Therapeutics
10/2022 - 09/2002
22Immunotherapy
01/2022 - 09/2002
5Ligation
01/2022 - 04/2007
4Transplantation
01/2020 - 08/2002